发明名称 |
PREDICTIVE MARKER OF DNMT1 INHIBITOR THERAPEUTIC EFFICACY AND METHODS OF USING THE MARKER |
摘要 |
Provided herein are methods for predicting efficacy of a DNA (cytosine-5)-methyltransferase 1 (DNMT1) inhibitor treatment in a subject having a cancer, methods of identifying a subject having a cancer that is more likely to respond to a DNMT1 inhibitor treatment, and methods of selecting a treatment for a subject having a cancer that include determining a level of SOX9 in a sample containing cells from a subject having a cancer. Also provided are methods of treating a subject having a cancer that include selectively administering a DNMT1 inhibitor to a subject having cancer determined to have an elevated level of SOX9 in a sample containing cells from the subject compared to a reference level. Also provided are antibodies and antigen-binding antibody fragments that specifically bind to SOX9, and nucleic acid sequences that contain at least 10 nucleotides complementary to a contiguous sequence present in a SOX9 nucleic acid for use in these methods. |
申请公布号 |
US2014329911(A1) |
申请公布日期 |
2014.11.06 |
申请号 |
US201214003714 |
申请日期 |
2012.03.07 |
申请人 |
Bates Paula J.;Malik Mohammad Tariq;Salipur Francesca R. |
发明人 |
Bates Paula J.;Malik Mohammad Tariq;Salipur Francesca R. |
分类号 |
G01N33/574;A61K31/045;C07K16/18;C12Q1/68 |
主分类号 |
G01N33/574 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for predicting efficacy of a DNA (cytosine-5)-methyltransferase 1 (DNMT1) inhibitor treatment in a subject having a cancer, the method comprising:
determining a level of SOX9 in a sample comprising cells from a subject having a cancer; and predicting increased efficacy of a DNMT1 inhibitor treatment in a subject that has an elevated level of SOX9 in the sample compared to a reference level, or decreased efficacy of a DNMT1 inhibitor treatment in a subject that has no significant change or a decreased level of SOX9 in the sample compared to a reference level. |
地址 |
Louisville KY US |